These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 27503607)

  • 61. Cathepsin B-Cleavable Cyclopeptidic Chemotherapeutic Prodrugs.
    Herceg V; Bouilloux J; Janikowska K; Allémann E; Lange N
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32962018
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A pH and redox dual stimuli-responsive poly(amino acid) derivative for controlled drug release.
    Gong C; Shan M; Li B; Wu G
    Colloids Surf B Biointerfaces; 2016 Oct; 146():396-405. PubMed ID: 27388968
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Thermosensitive magnetic liposomes with doxorubicin cell-penetrating peptides conjugate for enhanced and targeted cancer therapy.
    Lin W; Xie X; Yang Y; Fu X; Liu H; Yang Y; Deng J
    Drug Deliv; 2016 Nov; 23(9):3436-3443. PubMed ID: 27193383
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery.
    Bao Y; Yin M; Hu X; Zhuang X; Sun Y; Guo Y; Tan S; Zhang Z
    J Control Release; 2016 Aug; 235():182-194. PubMed ID: 27264552
    [TBL] [Abstract][Full Text] [Related]  

  • 65. pH-Responsive spherical nucleic acid for intracellular lysosome imaging and an effective drug delivery system.
    Li H; Zhou X; Yao D; Liang H
    Chem Commun (Camb); 2018 Apr; 54(28):3520-3523. PubMed ID: 29564423
    [TBL] [Abstract][Full Text] [Related]  

  • 66. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
    Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
    Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Doxorubicin-loaded biodegradable self-assembly zein nanoparticle and its anti-cancer effect: Preparation, in vitro evaluation, and cellular uptake.
    Dong F; Dong X; Zhou L; Xiao H; Ho PY; Wong MS; Wang Y
    Colloids Surf B Biointerfaces; 2016 Apr; 140():324-331. PubMed ID: 26764113
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prodrugs of anthracyclines for use in antibody-directed enzyme prodrug therapy.
    Florent JC; Dong X; Gaudel G; Mitaku S; Monneret C; Gesson JP; Jacquesy JC; Mondon M; Renoux B; Andrianomenjanahary S; Michel S; Koch M; Tillequin F; Gerken M; Czech J; Straub R; Bosslet K
    J Med Chem; 1998 Sep; 41(19):3572-81. PubMed ID: 9733483
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Modified gaphene oxide (GO) particles in peptide hydrogels: a hybrid system enabling scheduled delivery of synergistic combinations of chemotherapeutics.
    Schneible JD; Shi K; Young AT; Ramesh S; He N; Dowdey CE; Dubnansky JM; Lilova RL; Gao W; Santiso E; Daniele M; Menegatti S
    J Mater Chem B; 2020 May; 8(17):3852-3868. PubMed ID: 32219269
    [TBL] [Abstract][Full Text] [Related]  

  • 70. pH-responsive targeted and controlled doxorubicin delivery using hyaluronic acid nanocarriers.
    Gurav DD; Kulkarni AS; Khan A; Shinde VS
    Colloids Surf B Biointerfaces; 2016 Jul; 143():352-358. PubMed ID: 27022876
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Activable Cell-Penetrating Peptide Conjugated Prodrug for Tumor Targeted Drug Delivery.
    Cheng H; Zhu JY; Xu XD; Qiu WX; Lei Q; Han K; Cheng YJ; Zhang XZ
    ACS Appl Mater Interfaces; 2015 Jul; 7(29):16061-9. PubMed ID: 26161578
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Turn-on theranostic fluorescent nanoprobe by electrostatic self-assembly of carbon dots with doxorubicin for targeted cancer cell imaging, in vivo hyaluronidase analysis, and targeted drug delivery.
    Gao N; Yang W; Nie H; Gong Y; Jing J; Gao L; Zhang X
    Biosens Bioelectron; 2017 Oct; 96():300-307. PubMed ID: 28511113
    [TBL] [Abstract][Full Text] [Related]  

  • 73. EGFR-targeted prodrug activation using bioorthogonal alkene-azide click-and-release chemistry.
    Fairhall JM; Camilli JC; Gibson BH; Hook S; Gamble AB
    Bioorg Med Chem; 2021 Sep; 46():116361. PubMed ID: 34411983
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Endosomal escape by photo-activated fusion of liposomes containing a malachite green derivative: a novel class of photoresponsive liposomes for drug delivery vehicles.
    Hayashi K; Watanabe M; Iwasaki T; Shudou M; Uda RM
    Photochem Photobiol Sci; 2019 Jun; 18(6):1471-1478. PubMed ID: 30964475
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Self-Targeted Polysaccharide Prodrug Suppresses Orthotopic Hepatoma.
    Li D; Xu W; Li P; Ding J; Cheng Z; Chen L; Yan L; Chen X
    Mol Pharm; 2016 Dec; 13(12):4231-4235. PubMed ID: 27784155
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mesoporous silica nanobeans dual-functionalized with AIEgens and leaning pillar[6]arene-based supramolecular switches for imaging and stimuli-responsive drug release.
    Li X; Han J; Qin J; Sun M; Wu J; Lei L; Li J; Fang L; Yang YW
    Chem Commun (Camb); 2019 Dec; 55(94):14099-14102. PubMed ID: 31641718
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A doxorubicin prodrug activated by the staudinger reaction.
    van Brakel R; Vulders RC; Bokdam RJ; Grüll H; Robillard MS
    Bioconjug Chem; 2008 Mar; 19(3):714-8. PubMed ID: 18271515
    [TBL] [Abstract][Full Text] [Related]  

  • 78. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
    He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
    Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Regulating Drug Release Performance of Acid-Triggered Dimeric Prodrug-Based Drug Self-Delivery System by Altering Its Aggregation Structure.
    Yang C; Liu P
    Molecules; 2024 Jul; 29(15):. PubMed ID: 39125024
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A pH-responsive prodrug for real-time drug release monitoring and targeted cancer therapy.
    Li SY; Liu LH; Jia HZ; Qiu WX; Rong L; Cheng H; Zhang XZ
    Chem Commun (Camb); 2014 Oct; 50(80):11852-5. PubMed ID: 25145493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.